These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 7362556)

  • 1. Blockade of the different enzymatic steps in the synthesis of brain amines and memory (CAR) in hypobaric hypoxic rats treated and untreated with L. dopa.
    Boismare F; Le Poncin-Lafitte M; Rapin JR
    Aviat Space Environ Med; 1980 Feb; 51(2):126-8. PubMed ID: 7362556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. L-DOPA: from a biologically inactive amino acid to a successful therapeutic agent.
    Hornykiewicz O
    Amino Acids; 2002; 23(1-3):65-70. PubMed ID: 12373520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peculiarities of L: -DOPA treatment of Parkinson's disease.
    Kostrzewa RM; Nowak P; Kostrzewa JP; Kostrzewa RA; Brus R
    Amino Acids; 2005 Mar; 28(2):157-64. PubMed ID: 15750845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impairment of learning of conditioned avoidance response in rats after 6-hydroxydopamine.
    Plech A; Herman ZS; Brus R; Drybanski A
    Act Nerv Super (Praha); 1975 Sep; 17(3):176-8. PubMed ID: 1199684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of acute and chronic treatment with L-dopa on catecholamine turnover in the rat brain.
    Yamanaka Y; Kono S
    Hiroshima J Med Sci; 1977 Mar; 26(1):39-44. PubMed ID: 903270
    [No Abstract]   [Full Text] [Related]  

  • 6. Enhanced cortical dopamine output and antipsychotic-like effect of raclopride with adjunctive low-dose L-dopa.
    Eltayb A; Wadenberg ML; Svensson TH
    Biol Psychiatry; 2005 Aug; 58(4):337-43. PubMed ID: 16102547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Levodopa induction of Fos immunoreactivity in rat brain following partial and complete lesions of the substantia nigra.
    Cole DG; Growdon JH; DiFiglia M
    Exp Neurol; 1993 Apr; 120(2):223-32. PubMed ID: 8491280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of m-cholinoblockaders and physostigmine on emotional reactivity and catecholamine metabolism in the brain of rats].
    Zharkovskiĭ AM; Allikmets LKh; Annuk KE
    Farmakol Toksikol; 1978; 41(1):28-32. PubMed ID: 564287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The partial 5-HT(1A) agonist buspirone reduces the expression and development of l-DOPA-induced dyskinesia in rats and improves l-DOPA efficacy.
    Eskow KL; Gupta V; Alam S; Park JY; Bishop C
    Pharmacol Biochem Behav; 2007; 87(3):306-14. PubMed ID: 17553556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Increased efficacy of teturam combined with L-DOPA in experimental alcoholism in the rat].
    Gromova EA; Khesin II; Bobkova NV; Plakkhinas LA; Tokareva AE
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1986; 86(8):1226-31. PubMed ID: 3022507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. hypobaric hypoxia: central catecholamine levels and cortical PO2 and avoidance response in rats treated with apomorphine.
    Saligaut C; Moore N; Boulu R; Plotkine M; Leclerc JL; Prioux-Guyonneau M; Boismare F
    Aviat Space Environ Med; 1981 Mar; 52(3):166-70. PubMed ID: 7225019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Iron deficiency alters dopamine uptake and response to L-DOPA injection in Sprague-Dawley rats.
    Bianco LE; Wiesinger J; Earley CJ; Jones BC; Beard JL
    J Neurochem; 2008 Jul; 106(1):205-15. PubMed ID: 18363828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vesicular monoamine transporter-2 and aromatic L-amino acid decarboxylase gene therapy prevents development of motor complications in parkinsonian rats after chronic intermittent L-3,4-dihydroxyphenylalanine administration.
    Lee WY; Lee EA; Jeon MY; Kang HY; Park YG
    Exp Neurol; 2006 Jan; 197(1):215-24. PubMed ID: 16269145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [3H]DOPA formed from [3H]tyrosine in living rat brain is not committed to dopamine synthesis.
    Cumming P; Ase A; Kuwabara H; Gjedde A
    J Cereb Blood Flow Metab; 1998 May; 18(5):491-9. PubMed ID: 9591841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Relationship between memory enhancement induced by nitric oxide donor and brain ADP-ribosyltransferase in rats].
    Li CD; Zhang SY; Yuan B
    Sheng Li Xue Bao; 2000 Dec; 52(6):507-10. PubMed ID: 11941417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effects of external factors on biogenic cerebral amines].
    Schrammowa H; Rybakowski J
    Psychiatr Pol; 1972; 6(2):225-7. PubMed ID: 4402133
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of donepezil and lercanidipine on memory impairment induced by intracerebroventricular streptozotocin in rats.
    Sonkusare S; Srinivasan K; Kaul C; Ramarao P
    Life Sci; 2005 May; 77(1):1-14. PubMed ID: 15848214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A developmental role for catecholamines in Drosophila behavior.
    Pendleton RG; Rasheed A; Paluru P; Joyner J; Jerome N; Meyers RD; Hillman R
    Pharmacol Biochem Behav; 2005 Aug; 81(4):849-53. PubMed ID: 16051344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cholinergic mechanism--monoamines relation in certain brain structures.
    Izquierdo JA
    Prog Drug Res; 1972; 16():334-63. PubMed ID: 4405290
    [No Abstract]   [Full Text] [Related]  

  • 20. Acetyl-L-carnitine ameliorates hypobaric hypoxic impairment and spatial memory deficits in rats.
    Barhwal K; Singh SB; Hota SK; Jayalakshmi K; Ilavazhagan G
    Eur J Pharmacol; 2007 Sep; 570(1-3):97-107. PubMed ID: 17610872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.